Gene · 2357
Papers4,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings. | Brain Sci | 2023 | 38002561 | PubTator, text mining | PubMed |
| Neutrophils in Inflammatory Diseases: Unraveling the Impact of Their Derived Molecules and Heterogeneity. | Cells | 2023 | 37998356 | PubTator, text mining | PubMed |
| Chemotherapy in pediatric brain tumor and the challenge of the blood-brain barrier. | Cancer Med | 2023 | 37997517 | PubTator, text mining | PubMed |
Naïve Huntington's disease microglia mount a normal response to inflammatory stimuli but display a partially impaired development of innate immune tolerance that can be counteracted by ganglioside GM1. | J Neuroinflammation | 2023 | 37996924 | PubTator, text mining | PubMed |
| Characterization of genomic instability-related genes predicts survival and therapeutic response in lung adenocarcinoma. | BMC Cancer | 2023 | 37974107 | PubTator, text mining | PubMed |
| The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment. | Cell Biosci | 2023 | 37968699 | PubTator, text mining | PubMed |
| Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis. | Front Immunol | 2023 | 37965344 | PubTator, text mining | PubMed |
| Stimulation of the Pro-Resolving Receptor Fpr2 Reverses Inflammatory Microglial Activity by Suppressing NFκB Activity. | Int J Mol Sci | 2023 | 37958978 | PubTator, text mining | PubMed |
| KYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer. | Int J Genomics | 2023 | 37954130 | PubTator, text mining | PubMed |
| WITHDRAWN: Larixol is not an inhibitor of Gαi containing G proteins and lacks effect on signaling mediated by human neutrophil expressed formyl peptide receptors. | Biochem Pharmacol | 2023 | 37952896 | PubTator, text mining | PubMed |
| Deep phenotyping of the lipidomic response in COVID-19 and non-COVID-19 sepsis. | Clin Transl Med | 2023 | 37948331 | PubTator, text mining | PubMed |
| Full-Length NAD+-I Riboswitches Bind a Single Cofactor but Cannot Discriminate against Adenosine Triphosphate. | Biochemistry | 2023 | 37947391 | PubTator, text mining | PubMed |
| Advanced drug delivery and therapeutic strategies for tuberculosis treatment. | J Nanobiotechnology | 2023 | 37946240 | PubTator, text mining | PubMed |
| Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study. | BMC Cancer | 2023 | 37946141 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction as a possible trigger of neuroinflammation at post-traumatic stress disorder (PTSD). | Front Physiol | 2023 | 37942228 | PubTator, text mining | PubMed |
| Analysis of damage-associated molecular patterns in amyotrophic lateral sclerosis based on ScRNA-seq and bulk RNA-seq data. | Front Neurosci | 2023 | 37942135 | PubTator, text mining | PubMed |
| PGF2α signaling drives fibrotic remodeling and fibroblast population dynamics in mice. | JCI Insight | 2023 | 37934604 | PubTator, text mining | PubMed |
| Association of triglyceride-glucose index and neutrophil-to-lymphocyte ratio with coronary artery disease. | BMC Cardiovasc Disord | 2023 | 37915029 | PubTator, text mining | PubMed |
| Exploring the role of LIAS-related cuproptosis in systemic lupus erythematosus. | Lupus | 2023 | 37903189 | PubTator, text mining | PubMed |
| Updates in SJS/TEN: collaboration, innovation, and community. | Front Med (Lausanne) | 2023 | 37901413 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2357/papers?page=19